Prophylactic IL-12 treatment reduces postoperative metastasis: Mediation by increased numbers but not cytotoxicity of NK cells

Yossi Schwartz, Roi Avraham, Marganit Benish, Ella Rosenne, Shamgar Ben-Eliyahu

Research output: Contribution to journalArticlepeer-review

Abstract

Despite a promising potential, interleukin-12 immunotherapy has yielded limited clinical success while causing perilous toxicities. Here we study a context in which IL-12 may prove clinically beneficial-the removal of the primary tumor, when cell-mediated immunity (CMI) may eradicate minimal residual disease (MRD), but is inhibited by postoperative immunosuppression, potentially leading to enhanced malignant progression. F344 rats were preoperatively treated with IL-12 and inoculated postoperatively with syngeneic MADB106 tumor cells. An optimal regimen of eight-day sustained exposure to IL-12 was developed (1 μg/rat/day), which caused mild side effects, increased baseline resistance to experimental MADB106 metastasis, and abolished the promotion of metastasis by laparotomy and other immunosuppressive paradigms. Depletion of NK cells indicated their major role in controlling MADB106 metastasis in naïve and IL-12 treated rats. Studying NK cytotoxicity, we found that IL-12 did not potentiate activity per NK cell, nor protected it from suppression by surgery. However, IL-12 increased the numbers of NK cells in the circulation and marginating pulmonary pool of naïve and operated rats, and correspondingly increased total NK activity in these compartments. Therefore, this study indicates anti-tumor effects of IL-12 based on increased numbers of strategically located NK cells, and advocates a prophylactic approach against the potential metastasis-promoting effects of surgery.

Original languageEnglish
Pages (from-to)211-223
Number of pages13
JournalBreast Cancer Research and Treatment
Volume107
Issue number2
DOIs
StatePublished - Jan 2008

Keywords

  • Active immunotherapy
  • Cellular immunity
  • Cytokines
  • IL-12
  • Surgery

Fingerprint

Dive into the research topics of 'Prophylactic IL-12 treatment reduces postoperative metastasis: Mediation by increased numbers but not cytotoxicity of NK cells'. Together they form a unique fingerprint.

Cite this